Skip to main content

Cytotoxicity testing

MTIF offers in vitro, cell-based cytotoxicity testing using established human and mammalian cell models to assess the safety and biological impact of materials, compounds, and formulations. MTIF is able to offer testing to ISO 10993-5 and 12 standards.

MTIF is also seeking partners for ISO 17025 accreditation for routine analysis.

Hamamatsu cytotoxicity testing

Testing Services

Our capabilities include viability and toxicity assays, high-content fluorescence readouts, flow cytometry analysis, and advanced microscopy, including confocal and live-cell imaging, to study cell health, death pathways, and dose–response effects.

Real-time kinetic plate imaging enables compound addition directly onto live cells with simultaneous monitoring of cellular responses across all wells. High-temporal-resolution measurements, acquired at sub-second intervals up to 120 measurements per second, allow detailed assessment of dynamic and transient cytotoxic effects that are not captured by endpoint assays alone.

Hamamatsu cytotoxicity testing

Specialist equipment

The Medical Technologies Innovation Facility holds a number of specialist pieces of equipment in house, including the Hamamatsu FDSS µCELL kinetic plate imager and GloMax plate reader our flow cytometry equipment, our full imaging suite  and our new Nuclear magnetic resonance (NMR)

 

Explore more

Microscopy

Drug development and discovery

MTIF’s unique mixture of specialist equipment, facilities and expertise enables us to offer research and consultation services for a variety of drug development and discovery techniques.

Hamamatsu cytotoxicity testing

Clinical Research Services

MTIF stands at the forefront of clinical research – discover how MTIF can assist your needs.